News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

Multiple Myeloma Trastuzumab-DM1 Endometrial Cancer Anacor (ANAC) Illumina (ILMN) Prosensa (RNA) Vitae Pharmaceuticals (VTAE) SUNESIS PHARMACEUTICALS (SNSS) Sequenom (SQNM) Idenix (IDIX) Bristol-Myers Squibb (BMY) PORTOLA (PTLA) Merck (MRK) Human Longevity (HLI) Jazz Pharmaceuticals (JAZZ) JUNO (JUNO) Ocular Therapeutix (OCUL) Sanofi-Aventis (SAN) Regeneron (REGN) Micromet (MITI) ARCA (ABIO) ImmunoGen (IMGN) Ridaforolimus Alnylam (ALNY) Prolor Biotech (PBTH) AstraZeneca (AZN) Tysabri INNOVIVA (INVA) Amgen (AMGN) Onyx (ONXX) SYNTA (SNTA) C4 Therapeutics Editas (EDIT) Vertex (VRTX) OSI (OSIP) Ariad (ARIA) Velcade (bortezomib) CEMPRA (CEMP) Biocryst (BCRX) REGULUS (RGLS) Rapamune Dynavax (DVAX) Theravance Bio Pharma (TBPH) Agenus (AGEN) ISIS (ISIS) NANTKWEST (NK) Dendreon (DNDN) Roche (ROCHE) KERYX (KERX) PTC Therapeutics (PTCT) Roche (RHHBY) GUARDIAN HEALTH Auspex (ASPX) Intrexon (XON) Gilead (GILD) IDERA (IDRA) TOKAI (TKAOI) Elan (ELN) Telaprevir Sarepta (SRPT) Spike Therapeutics (ONCE) Zerenex Incyte (INCY) Galena (GALE) JOUNCE THERAPEUTICS (JNCE) ARGOS (ARGS) Intercept (ICPT) Valeant Pharmaceuticals International (VRX) Cytokinetics (CYTK) ADVENTRIX (ANX) Alder Biopharmaceuticals (ALDR) CRISPR Therapeutics (CRSP) Sangamo (SGMO) Revlimid (lenolidamide) KITE (KITE) Xoma (XOMA) CompuGen (CGEN) ABBVIE (ABBV) RenenxBio (RGNX) galapagos (GLPG) NOVOCURE (NVCR) Ziofpharm (ZIOP) GlaxoSmithKline (GSK) Advaxis (ADXS) Inovio (INO) AGOS (ARGS) MODERNA Global Cell Therapeutics (GBT) ACADIA (ACAD) Agenus (AGEN Intermune (ITMN) Anadys (ANDS) AERIE PHARMACEUTICALS SERES THERAPEUTICS (MCRB) Theravance (THRX) Bellicum (BLCM) Abbott Laboratories (ABT) Pluristem (PSTI) Array Pharmaceuticals (ARRY) Adaptimmune (ADAP) HALOZYME (HALO) Genentech Benlysta (belimumab) Sanofi (SNA) Sanofi (SNY) Aimmune Therapeutics (AIMT) NEKTAR (NKTR)) Herceptin BIOMARIN (BMRN) Ionis (IONS) VANDA (VNDA) Biogen Idec (BIIB) ZALTRAP™ Mirati Therapeutics (MRTX) Seattle Genetics (SGEN) Exelixis (EXEL) Human Genome Sciences (HGSI)